Adelaide Research & Scholarship: Search

Search

Results 11-20 of 24 (Search time: 0.005 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2012	Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects	Gelston, E.; Coller, J.; Lopatko, O.; James, H.; Schmidt, H.; White, J.; Somogyi, A.
	2008	Exposure to opioid maintenance treatment reduces long-term mortality	Gibson, A.; Degenhardt, L.; Mattick, R.; Ali, R.; White, J.; O'Brien, S.
	2003	Buprenorphine versus methadone maintenance: a cost-effectiveness analysis	Doran, C.; Shanahan, M.; Mattick, R.; Ali, R.; White, J.; Bell, J.
	2005	The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS)	Ross, J.; Teesson, M.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R.
	2008	Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects	La Vincente, S.; White, J.; Somogyi, A.; Bochner, F.; Chapleo, C.
	2008	Electrocardiogram characteristics of methadone and buprenorphine maintained subjects	Athanasos, P.; Farquharson, A.; Compton, P.; Psaltis, P.; Hay, J.
	2003	Pharmacokinetics of high-dose buprenorphine following single administration of sublingual tablet formulations in opioid naive healthy male volunteers under a naltrexone block	McAleer, S.; Mills, R.; Polack, R.; Hussain, T.; Rolan, P.; Gibbs, A.; Mullins, F.; Hussein, F.
	2003	Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine	Lopatko, O.; White, J.; Huber, A.; Ling, W.
	2011	Post-marketing surveillance of buprenorphine-naloxone in Australia: Diversion, injection and adherence with supervised dosing	Larance, B.; Degenhardt, L.; Lintzeris, N.; Bell, J.; Winstock, A.; Dietze, P.; Mattick, R.; Ali, R.; Horyniak, D.
	2012	Maintenance drugs to treat opioid dependence	Farrell, M.; Wodak, A.; Gowing, L.